ProMIS Neurosciences (PMN) Return on Assets [ROA] (2022 - 2026)
ProMIS Neurosciences (PMN) recorded Return on Assets [ROA] of -70.05% in Q2 2026, up 172.50 percentage points from -242.54% a year earlier and up 38.02 percentage points from the prior quarter.
ProMIS Neurosciences (PMN) Return on Assets [ROA] (2022 - 2026) Analysis & Trends
For FY2025, ProMIS Neurosciences reported Return on Assets [ROA] of -286.18%, down 182.73 percentage points from FY2024.
- Annual Return on Assets [ROA] has a three-year change of -94.37 percentage points (FY2022 to FY2025).
- Across earlier years, Return on Assets [ROA] came in at -103.46% in FY2024 (+35.40 pp), -138.85% in FY2023 (+52.97 pp) and -191.82% in FY2022.
- The Q2 2026 figure is the highest quarterly Return on Assets [ROA] in data going back to Q3 2022.
- On a year-over-year basis, Return on Assets [ROA] rose in six of the last eight quarters, with an average year-over-year change of +36.75 percentage points.
- Peak year-over-year performance for Return on Assets [ROA] in the last five years was a gain of 293.19 percentage points in Q4 2023, against a drop of 184.54 percentage points in Q4 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at -108.06% (Q1 2026), -262.40% (Q4 2025) and -228.61% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 10.47% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 28.37% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 2.14% |
| 10 | ProMIS Neurosciences | 84.30 Mn | -54.60 Mn | - | -70.05% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -70.05% |
| Mar 31, 2026 | -108.06% |
| Dec 31, 2025 | -262.40% |
| Sep 30, 2025 | -228.61% |
| Jun 30, 2025 | -242.54% |
| Mar 31, 2025 | -126.61% |
| Dec 31, 2024 | -77.86% |
| Sep 30, 2024 | -114.02% |
| Jun 30, 2024 | -521.78% |
| Mar 31, 2024 | -153.43% |
| Dec 31, 2023 | -91.36% |
| Sep 30, 2023 | -196.50% |
| Jun 30, 2023 | -759.20% |
| Mar 31, 2023 | -432.42% |
| Dec 31, 2022 | -384.55% |
| Sep 30, 2022 | -254.66% |
ProMIS Neurosciences Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=PMN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "PMN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=PMN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();